InvestLog
MAZE logo

MAZE

Maze Therapeutics, Inc.NASDAQHealthcare
$28.71-1.17%ClosedMarket Cap: $1.43B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-31JP Morgan—Overweight—
2026-03-25HC Wainwright & Co.—Buy—
2026-03-25BTIG—Buy—
2026-03-16Wedbush—Outperform—
2026-03-04Guggenheim—Buy—
2026-01-16BTIG—Buy—
2025-12-03HC Wainwright & Co.—Buy—
2025-11-07Wedbush—Outperform—
2025-09-29JP Morgan—Overweight—
2025-09-18HC Wainwright & Co.—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Thu Dec 31$-3.14$1.3M8
Fri Dec 31$-3.42$6.2M7
Sun Dec 31$-3.76$38.6M6
Mon Dec 31$-3.91$70.8M4